Cyclosporin Pharmacokinetics after Intravenous and Oral Administration in Patients with Crohn's Disease

References

• Hess A D, Colombani PM. Mechanism of action: in vitro studies. Prog Allergy 1986; 38: 198–221
   PubMedGoogle Scholar
• Brynskov J, Freund L, Nørby Rasmussen S. Final report on a placebo-controlled, double-blind, randomised, multicentre trial of cyclosporin treatment in active chronic Crohn's disease. Scand J Gastroenterol 1991; 26: 689–95
   PubMed Web of Science ®Google Scholar
• Brynskov J, Freund L, Nørby Rasmussen S. A Placehocontrolled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321: 845–50
   PubMed Web of Science ®Google Scholar
• Allam B F, Tillman J E, Thomson T J, Crossling F T, Gilbert LM. Effective intravenous cyclosporin therapy in a patient with severe Crohn's disease on parenteral nutrition. Gut 1987; 28: 1166–9
   PubMedGoogle Scholar
• Marbet U A, Gyr K, Stadler GA. Controlled study of cyclosporin versus corticosteroids in acute Crohn's disease: methodology and early findings. Cyclosporin in autoimmune diseases, R Schindler. Springer-Verlag, Berlin 1985; 188–9
   Google Scholar
• Ptachcinski R J, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet 1986; 11: 107–32
   PubMed Web of Science ®Google Scholar
• McMillan MA. Clinical pharmacokinetics of cyclosporin. Pharmacol Ther 1989; 42: 135–56
   PubMed Web of Science ®Google Scholar
• Lindholm A. Factors influencing the pharmacokinetics of cyclosporin in man. Ther Drug Monit 1991; 13: 465–77
   PubMed Web of Science ®Google Scholar
• Brynskov J. The role of cyclosporine therapy in Crohn's disease. A review. Dig Dis 1991; 9: 236–44
   PubMedGoogle Scholar
• Brynskov J, Binder V, Riis P. Low-dose cyclosporin for Crohn's disease: implications for clinical trials. Aliment Pharmacol Ther 1989; 3: 135–42
   PubMed Web of Science ®Google Scholar
• Malchow H, Ewe K, Brandes J W. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249–66
   PubMed Web of Science ®Google Scholar
• Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn's disease-based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 146–50
   PubMed Web of Science ®Google Scholar
• Harvey R F, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514
   PubMed Web of Science ®Google Scholar
• Karlsson M O, Lindberg-Freijs A. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses. J Pharmacokin Biopharm 1990; 18: 293–311
   PubMedGoogle Scholar
• Gibaldi M, Perrier D. Pharmacokinetics. 2nd edition. Dekker, New York 1982
   Google Scholar
• Grevel J, Nüesch E, Abisch E, Kutz K. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subject. Eur J Clin Pharmacol 1986; 31: 211–6
   PubMed Web of Science ®Google Scholar
• Reymond J-P, Steimer J-L, Niederberger W. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers. J Pharmacokin Biopharm 1988; 16: 331–53
   PubMedGoogle Scholar
• Van de Kamer J H, Huinink H TB, Weyers HA. Rapid method for determination of fat in faeces. J Biol Chem 1949; 177: 423–31
   Google Scholar
• Gupta S K, Manfro R C, Tomlanovich S J, Garmbertoglio J G, Garovoy M R, Benet LZ. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration. J Clin Pharmacol 1990; 30: 643–53
   PubMed Web of Science ®Google Scholar
• Sandborn W J, Strong R M, Forland S C, Chase R E, Cutler RE. The pharmacokinetics and colonic tissue concentrations of cyclosporin after IV, oral, and enema administration. J Clin Pharmacol 1991; 31: 7680
   Google Scholar
• Wadhwa N K, Schroeder T J, O'Flaherty E, Pesce A J, Myre S A, First MR. The effect of oral metoclopramide on the absorption of cyclosporin. Transplant Proc 1987; 19: 1730–3
   PubMed Web of Science ®Google Scholar
• Venkataramanan R, Burckart G J, Ptachinski RJ. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation. Semin Liver Dis 1985; 5: 357–68
   PubMed Web of Science ®Google Scholar
• Drewe J, Beglinger C, Kissel T. The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol 1992; 33: 39–43
   PubMed Web of Science ®Google Scholar
• Robert R, Sketris I S, Abraham I, Givner M L, MacDonald AS. Cyclosporine absorption in two patients with short bowel syndrome. Drug Intell Clin Pharm 1988; 22: 570–2
   PubMedGoogle Scholar
• Kolars J C, Awni W M, Merion R M, Watkins PB. First-pass metabolism of cyclosporin by the gut. Lancet 1991; 338: 1488–90
   PubMed Web of Science ®Google Scholar
• Atkinson K, Biggs J C, Britton K. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction. Br J Haematol 1984; 56: 223–31
   PubMedGoogle Scholar
• Holt D W, Marsden J T, Johnston A. Quality assessment of cyclosporine measurements: comparison of current methods. Transplant Proc 1990; 22: 1234–9
   PubMedGoogle Scholar
• Speck R F, Frey F J, Frey BM. Cyclosporine kinetics in renal transplant patients as assessed by high-performance liquid chromatography and radioimmunoassay using monoclonal and polyclonal antibodies. Transplantation 1989; 47: 802–6
   PubMedGoogle Scholar
• Yee G C, Kennedy M S, Storb R, Thomas ED. Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Transplantation 1984; 38: 511–13
   PubMedGoogle Scholar
• Ptachcinski R J, Venkataramanan R, Rosenthal J T, Burckart G J, Taylor R J, Hakala TR. Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther 1985; 38: 296300
   Google Scholar
• Ptachcinski R J, Burckart G J, Rosenthal J T. Cyclosporine pharmacokinetics in children following cadaveric renal transplantation. Transplant Proc 1986; 18: 7667
   Google Scholar
• Ptachcinski R J, Venkataramanan R, Burckart G J. Cyclosporine kinetics in healthy volunteers. J Clin Pharmacol 1987; 27: 243–8
   PubMedGoogle Scholar
• Groen PC. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 1988; 63: 1012–21
   PubMedGoogle Scholar
• Canafax D M, Cipolle R J, Hrushesky W JH. The chrono-pharmacokinetics of cyclosporin and its metabolites in recipients of pancreas allografts. Transplant Proc 1988; 20: 471–7, Suppl 2
   PubMed Web of Science ®Google Scholar
• Lichtinger S, Present DH. Cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990; 336: 16–9
   PubMedGoogle Scholar